AprilBio Co.,Ltd. (KOSDAQ:397030)
South Korea · Delayed Price · Currency is KRW 30,600
-2,100 (-6.42%)
At close: Jul 6, 2026
AprilBio Market Cap
AprilBio has a market cap or net worth of 716.46 billion as of July 7, 2026. Its market cap has increased by 75.71% in one year.
Market Cap
716.46B
Enterprise Value
633.96B
Revenue
725.35M
Ranking
n/a
PE Ratio
n/a
Stock Price
30,600.00
Market Cap Chart
Since July 28, 2022, AprilBio's market cap has increased from 229.75B to 716.46B, an increase of 211.85%. That is a compound annual growth rate of 33.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 716.46B | -43.77% |
| Dec 30, 2025 | 1.27T | 250.56% |
| Dec 30, 2024 | 363.46B | -0.02% |
| Dec 28, 2023 | 363.53B | 96.13% |
| Dec 29, 2022 | 185.35B | -19.33% |
| Jul 28, 2022 | 229.75B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aimed Bio | 1.60T |
| JS Link | 1.28T |
| Rznomics | 1.16T |
| Qurient | 823.46B |
| ROKIT Healthcare | 609.41B |
| Inventage Lab | 498.56B |
| Curocell | 484.95B |
| IntoCell | 345.51B |